Patents by Inventor Masuo Obinata

Masuo Obinata has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7964367
    Abstract: Novel human genes falling within the category of family genes relating to p53 gene which is known as a cell proliferation regulatory gene, and gene products thereof. A human p51 gene characterized by containing a base sequence encoding an amino acid sequence represented by SEQ ID NO:1; a human p51 gene having a base sequence consisting of the 145- to 1488-bases in the sequence represented by SEQ ID NO:2; vectors containing these genes; host cells transformed with these vectors; a process for producing a p51 protein having the amino sequence represented by SEQ ID NO:1; which comprises culturing the above host cells and harvesting the protein from the thus obtained culture; and the p51 protein having the amino acid sequence represented by SEQ ID NO:1.
    Type: Grant
    Filed: May 24, 2010
    Date of Patent: June 21, 2011
    Assignees: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Yoji Ikawa, Shuntaro Ikawa, Masuo Obinata
  • Publication number: 20100285499
    Abstract: Novel human genes falling within the category of family genes relating to p53 gene which is known as a cell proliferation regulatory gene, and gene products thereof. A human p51 gene characterized by containing a base sequence encoding an amino acid sequence represented by SEQ ID NO:1; a human p51 gene having a base sequence consisting of the 145- to 1488-bases in the sequence represented by SEQ ID NO:2; vectors containing these genes; host cells transformed with these vectors; a process for producing a p51 protein having the amino sequence represented by SEQ ID NO:1; which comprises culturing the above host cells and harvesting the protein from the thus obtained culture; and the p51 protein having the amino acid sequence represented by SEQ ID NO:1.
    Type: Application
    Filed: May 24, 2010
    Publication date: November 11, 2010
    Applicants: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Yoji IKAWA, Shuntaro IKAWA, Masuo OBINATA
  • Patent number: 7754857
    Abstract: Novel human genes falling within the category of family genes relating to p53 gene which is known as a cell proliferation regulatory gene, and gene products thereof. A human p51 gene characterized by containing a base sequence encoding an amino acid sequence represented by SEQ ID NO:1; a human p51 gene having a base sequence consisting of the 145- to 1488-bases in the sequence represented by SEQ ID NO:2; vectors containing these genes; host cells transformed with these vectors; a process for producing a p51 protein having the amino sequence represented by SEQ ID NO:1; which comprises culturing the above host cells and harvesting the protein from the thus obtained culture; and the p51 protein having the amino acid sequence represented by SEQ ID NO:1.
    Type: Grant
    Filed: July 8, 2008
    Date of Patent: July 13, 2010
    Assignees: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Yoji Ikawa, Shuntaro Ikawa, Masuo Obinata
  • Publication number: 20100167397
    Abstract: In accordance with the present invention, there are provided (1) various cell lines derived from hypothalamus and Langerhans islets of mammals, (2) process for producing an active peptide and expression cloning system of active peptide precursor gene using the cell line as a host, (3) a method of screening or evaluating a substance capable of acting on the cells using the cell line, (4) a method of screening or isolating a useful gene or useful peptide using the cell line and (5) a highly-sensitive and simple assay system for GPCR ligand used in the above expression cloning system.
    Type: Application
    Filed: September 18, 2009
    Publication date: July 1, 2010
    Applicant: KYOWA HAKKO KOGYO CO., LTD.
    Inventors: KATSUTOSHI SASAKI, KAZUMI MIURA, SATOSHI SAEKI, MISAKO SUZUKI, KAZUYA KISHIMOTO, HIROFUMI KUNITOMO, TATSUNARI NISHI, MASUO OBINATA
  • Patent number: 7553933
    Abstract: Novel human genes falling within the category of family genes relating to p53 gene which is known as a cell proliferation regulatory gene, and gene products thereof. A human p51 gene characterized by containing a base sequence encoding an amino acid sequence represented by SEQ ID NO:1; a human p51 gene having a base sequence consisting of the 145- to 1488-bases in the sequence represented by SEQ ID NO:2; vectors containing these genes; host cells transformed with these vectors; a process for producing a p51 protein having the amino sequence represented by SEQ ID NO:1; which comprises culturing the above host cells and harvesting the protein from the thus obtained culture; and the p51 protein having the amino acid sequence represented by SEQ ID NO:1.
    Type: Grant
    Filed: January 27, 2006
    Date of Patent: June 30, 2009
    Assignees: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Yoji Ikawa, Shuntaro Ikawa, Masuo Obinata
  • Publication number: 20090142783
    Abstract: Novel human genes falling within the category of family genes relating to p53 gene which is known as a cell proliferation regulatory gene, and gene products thereof. A human p51 gene characterized by containing a base sequence encoding an amino acid sequence represented by SEQ ID NO:1; a human p51 gene having a base sequence consisting of the 145- to 1488-bases in the sequence represented by SEQ ID NO:2; vectors containing these genes; host cells transformed with these vectors; a process for producing a p51 protein having the amino sequence represented by SEQ ID NO:1; which comprises culturing the above host cells and harvesting the protein from the thus obtained culture; and the p51 protein having the amino acid sequence represented by SEQ ID NO:1.
    Type: Application
    Filed: July 8, 2008
    Publication date: June 4, 2009
    Applicants: OTSUKA PHARMACEUTICAL CO., LTD., IKAWA, YOJI
    Inventors: Yoji IKAWA, Shuntaro Ikawa, Masuo Obinata
  • Patent number: 7316926
    Abstract: To provide an immortalized capillary pericyte line which maintains the original function/property of the cell line-deriving tissue, its establishment method, and the screening method for useful substance using the immortalized capillary pericyte line. Cerebral tissue of a transgenic rat carrying the large T antigen gene of SV40 thermo-sensitive mutant line tsA58 is homogenized and the resultant brain capillaries are treated with protease, thus obtained brain capillary cells are subcultured to establish an immortalized cell that expresses SV40 thermo-sensitive large T antigen, PDGF receptor ?, and Angiopoietin-1. In addition, the immortalized vascular pericyte line has ability to deposit calcium on matrix by dense culture.
    Type: Grant
    Filed: February 14, 2001
    Date of Patent: January 8, 2008
    Assignee: Japan Science and Technology Agency
    Inventors: Hisashi Iizasa, Kenji Hattori, Emi Nakashima, Tetsuya Terasaki, Masuo Obinata
  • Publication number: 20070105096
    Abstract: In accordance with the present invention, there are provided (1) various cell lines derived from hypothalamus and Langerhans islets of mammals, (2) process for producing an active peptide and expression cloning system of active peptide precursor gene using the cell line as a host, (3) a method of screening or evaluating a substance capable of acting on the cells using the cell line, (4) a method of screening or isolating a useful gene or useful peptide using the cell line and (5) a highly-sensitive and simple assay system for GPCR ligand used in the above expression cloning system.
    Type: Application
    Filed: April 16, 2003
    Publication date: May 10, 2007
    Inventors: Katsutoshi Sasaki, Kazumi Miura, Satoshi Saeki, Misako Suzuki, Kazuya Kishimoto, Hirofumi Kunitomo, Tatsunari Nishi, Masuo Obinata
  • Publication number: 20070104679
    Abstract: This invention provides a method to induce the differentiation of animal cells wherein said cells are brought into contact with cytokine only in a suitable growth phase of animal cells, and also provides a system to control the differentiation potency of animal cells wherein two or more cytokines are combined for use in the cultivation or growing of animal cells.
    Type: Application
    Filed: March 24, 2004
    Publication date: May 10, 2007
    Inventors: Masuo Obinata, Yoshihisa Suzuki
  • Publication number: 20070037178
    Abstract: In accordance with the present invention, there are provided (1) various cell lines derived from hypothalamus and Langerhans islets of mammals, (2) process for producing an active peptide and expression cloning system of active peptide precursor gene using the cell line as a host, (3) a method of screening or evaluating a substance capable of acting on the cells using the cell line, (4) a method of screening or isolating a useful gene or useful peptide using the cell line and (5) a highly-sensitive and simple assay system for GPCR ligand used in the above expression cloning system.
    Type: Application
    Filed: January 17, 2006
    Publication date: February 15, 2007
    Applicant: KYOWA HAKKO KOGYO CO., LTD.
    Inventors: Katsutoshi Sasaki, Kazumi Miura, Satoshi Saeki, Misako Suzuki, Kazuya Kishimoto, Hirofumi Kunitomo, Tatsunari Nishi, Masuo Obinata
  • Patent number: 7132276
    Abstract: Novel human genes falling whithin the category of family genes relating to p53 gene which is known as a cell proliferation regulatory gene, and gene products thereof. A human p51 gene characterized by containing a base sequence encoding an amino acid sequence represented by SEQ ID NO:1; a human p51 gene having a base sequence consisting of the 145- to 1488-bases in the sequence represented by SEQ ID NO:2; vectors containing these genes; host cells transformed with these vectors; a process for producing a p51 protein having the amino sequence represented by SEQ ID NO:1; which comprises culturing the above host cells and harvesting the protein from the thus obtained culture; and the p51 protein having the amino acid sequence represented by SEQ ID NO:1.
    Type: Grant
    Filed: March 24, 1999
    Date of Patent: November 7, 2006
    Assignees: Otsuka Pharmaceutical Co., Ltd
    Inventors: Yoji Ikawa, Shuntaro Ikawa, Masuo Obinata
  • Publication number: 20060115852
    Abstract: Novel human genes falling within the category of family genes relating to p53 gene which is known as a cell proliferation regulatory gene, and gene products thereof. A human p51 gene characterized by containing a base sequence encoding an amino acid sequence represented by SEQ ID NO:1; a human p51 gene having a base sequence consisting of the 145- to 1488-bases in the sequence represented by SEQ ID NO:2; vectors containing these genes; host cells transformed with these vectors; a process for producing a p51 protein having the amino sequence represented by SEQ ID NO:1; which comprises culturing the above host cells and harvesting the protein from the thus obtained culture; and the p51 protein having the amino acid sequence represented by SEQ ID NO:1.
    Type: Application
    Filed: January 27, 2006
    Publication date: June 1, 2006
    Inventors: Yoji Ikawa, Shuntaro Ikawa, Masuo Obinata
  • Publication number: 20060067914
    Abstract: The present invention provides an immortalized natural killer cell line retaining the function and characteristics intrinsic to natural killer cells, a method for establishing the same, a method for screening for useful substances using the immortalized natural killer cell line, and a cell vaccine. By culturing natural killer cells obtained by isolating natural killer cells from the spleen of a transgenic mouse to which a large T-antigen gene of SV40 temperature-sensitive mutant tsA58 is introduced, a cell line which proliferates and activates in the presence of Interleukin-2, has azurophilic granules within cytoplasm, and retains an ability to kill a target cell without presensitization and/or an ability to kill target cells coated with an antibody, is established.
    Type: Application
    Filed: April 26, 2005
    Publication date: March 30, 2006
    Inventors: Satoru Iizuka, Toshiyuki Takai, Yumi Ito, Kozue Ito, Masuo Obinata
  • Publication number: 20030175953
    Abstract: To provide an immortalized capillary pericyte line which maintains the original function/property of the cell line-deriving tissue, its establishment method, and the screening method for useful substance using the immortalized capillary pericyte line. Cerebral tissue of a transgenic rat carrying the large T antigen gene of SV40 thermo-sensitive mutant line tsA58 is homogenized and the resultant brain capillaries are treated with protease, thus obtained brain capillary cells are subcultured to establish an immortalized cell that expresses SV40 thermo-sensitive large T antigen, PDGF receptor &bgr;, and Angiopoietin-1. In addition, the immortalized vascular pericyte line has ability to deposit calcium on matrix by dense culture.
    Type: Application
    Filed: August 16, 2002
    Publication date: September 18, 2003
    Inventors: Hisashi Iizasa, Kenji Hattori, Emi Nakashima, Tetsuya Terasaki, Masuo Obinata
  • Publication number: 20020045254
    Abstract: Established cells derived from retinal capillary endothelial cells, choroid plexus epithelial cells, or brain capillary endothelial cells or a transgenic animal carrying a large T-antigen gene of an SV40 temperature sensitive mutant tsA58. The cell line derived from retinal capillary endothelial cells expresses a temperature sensitive SV40 large T-antigen, GLUT-1 transporter, and p-glycoprotein. The cell line derived from choroid plexus epithelial cells expresses a temperature sensitive SV40 large T-antigen gene and shows localization of Na+—K+ ATPase and GLUT-1 transporter in the cell membrane. When cultured in a monolayer, it shows the localization of Na+—K+ ATPase in the apical side. The cell line derived from brain capillary endothelial cells expresses a temperature sensitive SV40 large T-antigen, GLUT-1 transporter, p-glycoprotein, alkaline phosphatase, and &ggr;-glutamyltransferase.
    Type: Application
    Filed: March 29, 2001
    Publication date: April 18, 2002
    Inventors: Kenichi Hosoya, Tetsuya Terasaki, Masatsugu Ueda, Masuo Obinata
  • Patent number: 5776446
    Abstract: Lymphotoxin-producing human T-cell hybridomas are incubated in a medium containing phorbol myristate acetate, concanavalin-A or a mixture thereof, the resulting cells are fractionated by sucrose density-gradient centrifugation method to isolate a messenger RNA in 12.6S to 14.6S fractions, and a gene containing a part encoding a polypeptide having a lymphotoxin-activity is prepared from the messenger RNA. The gene is represented by the base sequence of the Table 1 as herein given. Using the present gene, a new lymphotoxin having the amino acid sequence (I) or (II) as given herein can be obtained by genetic engineering technology.
    Type: Grant
    Filed: May 16, 1994
    Date of Patent: July 7, 1998
    Assignee: Denki Kagaku Kogyo Kabushiki Kaisha
    Inventors: Toshiaki Osawa, Masuo Obinata, Yoshiyuki Ishii, Yoshio Kobayashi
  • Patent number: 5403725
    Abstract: Lymphotoxin-producing human T-cell hybridomas are incubated in a medium containing phorbol myristate acetate, concanavalin-A or a mixture thereof, the resulting cells are fractionated by sucrose density-gradient centrifugation method to isolate a messenger RNA in 12.6S to 14.6S fractions, and a gene containing a part encoding a polypeptide having a lymphotoxin-activity is prepared from the messenger RNA. The gene is represented by the nucleotide sequence of the Table 1 as herein given. Using the present gene, a new lymphotoxin having the amino acid sequence (I) or (II) as given herein can be obtained by genetic engineering technology.
    Type: Grant
    Filed: July 22, 1991
    Date of Patent: April 4, 1995
    Assignee: Denki Kagaku Kogyo Kabushiki Kaisha
    Inventors: Toshiaki Osawa, Masuo Obinata, Yoshiyuki Ishii, Yoshio Kobayashi